BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23028526)

  • 1. Adverse drug reactions in hospitalised children in Germany are decreasing: results of a nine year cohort-based comparison.
    Oehme AK; Rashed AN; Hefele B; Wong IC; Rascher W; Neubert A
    PLoS One; 2012; 7(9):e44349. PubMed ID: 23028526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study.
    Rashed AN; Wong IC; Cranswick N; Tomlin S; Rascher W; Neubert A
    Eur J Clin Pharmacol; 2012 May; 68(5):801-10. PubMed ID: 22166934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions.
    Thiesen S; Conroy EJ; Bellis JR; Bracken LE; Mannix HL; Bird KA; Duncan JC; Cresswell L; Kirkham JJ; Peak M; Williamson PR; Nunn AJ; Turner MA; Pirmohamed M; Smyth RL
    BMC Med; 2013 Nov; 11():237. PubMed ID: 24228998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study.
    Rashed AN; Wong IC; Cranswick N; Hefele B; Tomlin S; Jackman J; Lee K; Hon KL; Ong J; Ghaleb M; Chua SS; Hui TM; Rascher W; Neubert A
    Drug Saf; 2012 Jun; 35(6):481-94. PubMed ID: 22612852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions causing hospital admissions in childhood: a prospective, observational, single-centre study.
    Langerová P; Vrtal J; Urbánek K
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):560-4. PubMed ID: 24810357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
    Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
    Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived adverse drug reactions among non-institutionalized children and adolescents in Germany.
    Knopf H; Du Y
    Br J Clin Pharmacol; 2010 Sep; 70(3):409-17. PubMed ID: 20716242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.
    Impicciatore P; Choonara I; Clarkson A; Provasi D; Pandolfini C; Bonati M
    Br J Clin Pharmacol; 2001 Jul; 52(1):77-83. PubMed ID: 11453893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs.
    Dubrall D; Leitzen S; Toni I; Stingl J; Schulz M; Schmid M; Neubert A; Sachs B
    BMC Pharmacol Toxicol; 2021 Oct; 22(1):56. PubMed ID: 34620231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study.
    Kurian J; Mathew J; Sowjanya K; Chaitanya KR; Ramesh M; Sebastian J; Narayanappa D
    Indian J Pediatr; 2016 May; 83(5):414-9. PubMed ID: 26916890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.
    Haffner S; von Laue N; Wirth S; Thürmann PA
    Drug Saf; 2005; 28(5):453-64. PubMed ID: 15853446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in neonates: a prospective study.
    Belén Rivas A; Arruza L; Pacheco E; Portoles A; Diz J; Vargas E
    Arch Dis Child; 2016 Apr; 101(4):371-6. PubMed ID: 26819267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for adverse drug reactions in pediatric inpatients: A cohort study.
    Andrade PHS; Lobo IMF; da Silva WB
    PLoS One; 2017; 12(8):e0182327. PubMed ID: 28763499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients.
    Vázquez-Alvarez AO; Brennan-Bourdon LM; Rincón-Sánchez AR; Islas-Carbajal MC; Huerta-Olvera SG
    BMC Pharmacol Toxicol; 2017 Dec; 18(1):79. PubMed ID: 29216902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis.
    Hamre HJ; Witt CM; Glockmann A; Tröger W; Willich SN; Kiene H
    Drug Saf; 2006; 29(12):1173-89. PubMed ID: 17147463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.